United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Overall Market Size
2.1 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size: 2021 VS 2027
2.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, Prospects & Forecasts: 2016-2027
2.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales: 2016-2027
3 Company Landscape
3.1 Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players in United States Market
3.2 Top United States ICAD (Intracranial Atherosclerotic Disease) Pathology Companies Ranked by Revenue
3.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Companies
3.4 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Companies
3.5 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies in United States Market, by Revenue in 2020
3.7 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
3.8 Tier 1, Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Players in United States Market
3.8.1 List of Tier 1 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies in United States
3.8.2 List of Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Markets, 2021 & 2027
4.1.2 Stent
4.1.3 PTA Balloon
4.2 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
4.2.1 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
4.2.2 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
4.2.3 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
4.3 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales & Forecasts
4.3.1 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, 2016-2021
4.3.2 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, 2022-2027
4.3.3 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share, 2016-2027
4.4 By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue & Forecasts
5.2.1 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2021
5.2.2 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2022-2027
5.2.3 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
5.3 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales & Forecasts
5.3.1 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, 2016-2021
5.3.2 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, 2022-2027
5.3.3 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share, 2016-2027
5.4 By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Stryker
6.1.1 Stryker Corporation Information
6.1.2 Stryker Overview
6.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue in United States Market (2016-2021)
6.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Description
6.1.5 Stryker Recent Developments
6.2 Balt
6.2.1 Balt Corporation Information
6.2.2 Balt Overview
6.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue in United States Market (2016-2021)
6.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Description
6.2.5 Balt Recent Developments
6.3 TERUMO
6.3.1 TERUMO Corporation Information
6.3.2 TERUMO Overview
6.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue in United States Market (2016-2021)
6.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Description
6.3.5 TERUMO Recent Developments
6.4 MicroPort
6.4.1 MicroPort Corporation Information
6.4.2 MicroPort Overview
6.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue in United States Market (2016-2021)
6.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Description
6.4.5 MicroPort Recent Developments
6.5 Acandis
6.5.1 Acandis Corporation Information
6.5.2 Acandis Overview
6.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue in United States Market (2016-2021)
6.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Description
6.5.5 Acandis Recent Developments
7 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Production Capacity, Analysis
7.1 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Production Capacity, 2016-2027
7.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 ICAD (Intracranial Atherosclerotic Disease) Pathology Supply Chain Analysis
9.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Value Chain
9.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Upstream Market
9.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology in United States Market
Table 2. Top ICAD (Intracranial Atherosclerotic Disease) Pathology Players in United States Market, Ranking by Revenue (2019)
Table 3. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Companies, 2016-2021
Table 5. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Companies, (Units), 2016-2021
Table 6. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
Table 9. List of Tier 1 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Stent
Table 12. Major Manufacturers of PTA Balloon
Table 13. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), 2016-2021
Table 17. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), 2022-2027
Table 18. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), 2016-2021
Table 22. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), 2022-2027
Table 23. Stryker Corporation Information
Table 24. Stryker Description and Major Businesses
Table 25. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 27. Stryker Recent Developments
Table 28. Balt Corporation Information
Table 29. Balt Description and Major Businesses
Table 30. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 32. Balt Recent Developments
Table 33. TERUMO Corporation Information
Table 34. TERUMO Description and Major Businesses
Table 35. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 37. TERUMO Recent Developments
Table 38. MicroPort Corporation Information
Table 39. MicroPort Description and Major Businesses
Table 40. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 42. MicroPort Recent Developments
Table 43. Acandis Corporation Information
Table 44. Acandis Description and Major Businesses
Table 45. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table 47. Acandis Recent Developments
Table 48. ICAD (Intracranial Atherosclerotic Disease) Pathology Production Capacity (Units) of Key Manufacturers in United States Market, 2019-2021 (Units)
Table 49. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Capacity Market Share of Key Manufacturers, 2019-2021
Table 50. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Opportunities & Trends in United States Market
Table 51. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers in United States Market
Table 52. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints in United States Market
Table 53. ICAD (Intracranial Atherosclerotic Disease) Pathology Raw Materials
Table 54. ICAD (Intracranial Atherosclerotic Disease) Pathology Raw Materials Suppliers in United States Market
Table 55. Typical ICAD (Intracranial Atherosclerotic Disease) Pathology Downstream
Table 56. ICAD (Intracranial Atherosclerotic Disease) Pathology Downstream Clients in United States Market
Table 57. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors and Sales Agents in United States Market
List of FiguresFigure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
Figure 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
Figure 3. ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
Figure 4. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview: 2020
Figure 5. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, 2016-2027 (US$, Mn)
Figure 7. ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in United States Market: 2016-2027 (Units)
Figure 8. The Top 3 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2020
Figure 9. Stent Product Picture
Figure 10. PTA Balloon Product Picture
Figure 11. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share, 2016-2027
Figure 12. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 13. By Type - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit), 2016-2027
Figure 14. Hospital
Figure 15. Clinic
Figure 16. Other
Figure 17. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share, 2016-2027
Figure 18. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share, 2016-2027
Figure 19. By Application - United States ICAD (Intracranial Atherosclerotic Disease) Pathology Price (USD/Unit), 2016-2027
Figure 20. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Production Capacity (Units), 2016-2027
Figure 26. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Value Chain
Figure 27. Marketing Channels